| Mrs Tari S Anderson, MD | |
|
5777 Kellogg Avenue, Cincinnati, OH 45230 | |
| (513) 232-3232 | |
| (513) 232-3202 |
| Full Name | Mrs Tari S Anderson |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 36 Years |
| Location | 5777 Kellogg Avenue, Cincinnati, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326142829 | NPI | - | NPPES |
| 6418350001 | Other | OH | MEDICARE DME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 35058827 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bethesda North | Cincinnati, OH | Hospital |
| Good Samaritan Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trihealth H Llc | 1850570458 | 668 |
News Archive
Ongoing media and community campaigns have helped to destigmatise, and inform about, a wide range of mental illnesses. However new Macquarie University research into postnatal depression has revealed that the identification and uptake of treatment for this disorder remains a serious problem among sufferers.
DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.
Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 10,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD"). with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
› Verified 9 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
Ongoing media and community campaigns have helped to destigmatise, and inform about, a wide range of mental illnesses. However new Macquarie University research into postnatal depression has revealed that the identification and uptake of treatment for this disorder remains a serious problem among sufferers.
DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.
Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 10,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD"). with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Tari S Anderson, MD 5777 Kellogg Ave, Cincinnati, OH 45230-7142 Ph: (513) 232-3232 | Mrs Tari S Anderson, MD 5777 Kellogg Avenue, Cincinnati, OH 45230 Ph: (513) 232-3232 |
News Archive
Ongoing media and community campaigns have helped to destigmatise, and inform about, a wide range of mental illnesses. However new Macquarie University research into postnatal depression has revealed that the identification and uptake of treatment for this disorder remains a serious problem among sufferers.
DelMar Pharmaceuticals, Inc., a clinical-stage oncology company, today announced the presentation of promising new data supporting the activity of its lead drug compound, VAL-083, in the treatment of non-small cell lung cancer (NSCLC) at the AACR's New Horizons in Cancer Research: Harnessing Breakthroughs – Targeting Cures. The conference takes place October 9th to 12th in Pudong, Shanghai.
Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 10,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD"). with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
› Verified 9 days ago
Ellen W Feld, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 8231 Cornell Rd, Suite 320, Cincinnati, OH 45249 Phone: 513-794-1500 Fax: 513-794-1500 | |
Renee Louise Klee, CNM Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 7495 State Rd, Suite 300, Cincinnati, OH 45255 Phone: 513-231-3447 Fax: 513-231-3761 | |
Dr. Laura Hampel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10475 Reading Rd, Cincinnati, OH 45241 Phone: 513-563-2202 Fax: 513-751-2327 | |
Helmut F Schellhas, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3219 Clifton Ave, Suite 100, Cincinnati, OH 45220 Phone: 513-862-1888 Fax: 513-862-3616 | |
Dr. Sarah E Bartlett, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8350 E Kemper Rd Ste A, Cincinnati, OH 45249 Phone: 513-404-4166 | |
Anuja Gupta, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 8000 5 Mile Rd Ste 207, Cincinnati, OH 45230 Phone: 513-474-2870 Fax: 513-688-8585 | |
Dr. Ajit Gubbi, D.O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 601 Ivy Gtwy Ste 1100, Cincinnati, OH 45245 Phone: 513-751-2273 Fax: 513-751-1840 |